Applied BioMath

About:

Applied BioMath helps biotechnology and pharmaceutical companies accelerate and de-risk drug research and development.

Website: http://www.appliedbiomath.com

Twitter/X: AppliedBioMath

Top Investors: National Institutes of Health

Description:

Applied BioMath helps biotechnology and pharmaceutical companies accelerate and de-risk drug research and development. Its goal is to reduce late-stage attrition by applying advanced mathematical and systems biology techniques at critical decision points in the drug discovery process. They accomplish this by employing internally developed algorithms where systems approach naturally drive quantitative decisions to provide customers with a thorough understanding of the optimal way forward with their drug discovery efforts. Through high-performance computational biology and large dataset analyses, their predictive models provide best-in-industry insight allowing our customers to realize the most cost-effective method for drug discovery. The company was founded in 2013 by Dr. John Burke, Dr. Joshua Apgar, and Andrew Sutherland.

Total Funding Amount:

$505000

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Concord, Massachusetts, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)appliedbiomath.com

Founders:

Andrew Sutherland, John M. Burke, Joshua Apgar

Number of Employees:

11-50

Last Funding Date:

2023-08-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai